People News

Share this article:

AcelRx Pharmaceuticals, a California-based privately-held pharmaceutical company, announced the hiring of Nigel Ray as VP, business development. Ray will lead AcelRx's partnering efforts for mid- and late-stage products, and report to Thomas Schreck, CEO. Ray was most recently VP, business development at Limerick BioPharma.

Sundia MediTech, a pharmaceutical contract research organization, appointed Charles Maher to SVP, sales and marketing. Maher was previously EVP, global sales and marketing at Azopharma Product Development Group, a CRO based in Florida. In his new role, Maher will be responsible for global business development, and will report to Sundia chairman and CEO Xiaochuan Wang.

Lannett Company, a generics manufacturer, appointed Keith Ruck as VP, chief financial officer, reporting to Arthur Bedrosian, president and CEO. Buck will handle all accounting, treasury and investor relations, as well as assist in new business development and M&A activities. Ruck was most recently VP, finance, at Maax KSD Corporation.  

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters